Advocate Group’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
Other funds holding CL
SP
PAM
CIM
AAMU
JIC
WG
Advocate Group's CL Position: Q2 2026 in Review
Advocate Group reduced its Colgate-Palmolive (CL) stake by 0.7% in Q2 2026, selling an estimated $5.16K and leaving 8,322 shares worth $763K. The position accounts for 0.11% of the portfolio, ranked #89.
Advocate Group first reported a position in CL in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.94M in Q2 2022. 606 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Advocate Group held 8,322 shares of Colgate-Palmolive worth $763K as of Q2 2026.
- Advocate Group sold 59 Colgate-Palmolive shares in Q2 2026, an estimated $5.16K.
- Colgate-Palmolive made up 0.11% of Advocate Group's portfolio in Q2 2026, its #89 holding.
- Advocate Group first reported a position in Colgate-Palmolive in Q2 2022 and has held it in 17 quarters since.
- Advocate Group's Colgate-Palmolive position peaked at $1.94M in Q2 2022.
- 606 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Advocate Group's 13F filing for Q2 2026, filed 17 Jul 2026.